Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yuan-Ming Lee & Y. Henry Sun. (2015) Drosophila as a model to study the role of glia in neurodegeneration. Journal of Neurogenetics 29:2-3, pages 69-79.
Read now
Read now
Nataša Klepac, Mario Habek, Ivan Adamec, Anabella Karla Barušić, Ivo Bach, Eduard Margetić & Ivo Lušić. (2012) An update on the management of young-onset Parkinson’s disease. Degenerative Neurological and Neuromuscular Disease 2, pages 53-62.
Read now
Read now
Jonathan R Evans & Roger A Barker. (2011) Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's disease. Expert Opinion on Pharmacotherapy 12:8, pages 1249-1258.
Read now
Read now
Kumar SAPKOTA, Seung KIM, Myung-Kon KIM & Sung-Jun KIM. (2010) A Detoxified Extract of Rhus verniciflua Stokes Upregulated the Expression of BDNF and GDNF in the Rat Brain and the Human Dopaminergic Cell Line SH-SY5Y. Bioscience, Biotechnology, and Biochemistry 74:10, pages 1997-2004.
Read now
Read now
Articles from other publishers (57)
Mohd Aizuddin Mohd Lazaldin, Lidawani Lambuk, Suhana Ahmad & Rohimah Mohamud. 2023. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
187
243
.
Francieli Cristina Krey, Bruna Alvim Stocchero, Kerstin Camile Creutzberg, Bernardo Aguzzoli Heberle, Saulo Gantes Tractenberg, Li Xiang, Wei Wei, Bruno Kluwe-Schiavon & Thiago Wendt Viola. (2021) Neurotrophic Factor Levels in Preterm Infants: A Systematic Review and Meta-Analysis. Frontiers in Neurology 12.
Crossref
Crossref
Eoin Mulroy, Barry Snow, Arnold Bok, Mark Simpson, Andrew Smith, Kenneth M. Taylor, Michelle Lockhart, B.B. Janice Lam, Christopher Frampton, Gregory Finucane, Patrick Schweder, Benson Chen, Adele McMahon & Lorraine Macdonald. (2021) A long-term follow-up of safety and clinical efficacy of NTCELL® [Immunoprotected (Alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease. Parkinsonism & Related Disorders 82, pages 128-132.
Crossref
Crossref
Brian V. Lien, Nolan J. Brown, Seth C. Ransom, Brandon M. Lehrich, Shane Shahrestani, Ali R. Tafreshi, Ryan C. Ransom & Ronald Sahyouni. (2020) Enhancing peripheral nerve regeneration with neurotrophic factors and bioengineered scaffolds: A basic science and clinical perspective. Journal of the Peripheral Nervous System 25:4, pages 320-334.
Crossref
Crossref
Muhammad Amir, Michael Yu, Peijian He & Shanthi Srinivasan. (2020) Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease. Frontiers in Medicine 7.
Crossref
Crossref
Rafieh Alizadeh, Payam Zarrintaj, Seyed Kamran Kamrava, Zohreh Bagher, Mohammad Farhadi, Fatemeh Heidari, Ali Komeili, Tomy J. Gutiérrez & Mohammad Reza Saeb. (2019) Conductive hydrogels based on agarose/alginate/chitosan for neural disorder therapy. Carbohydrate Polymers 224, pages 115161.
Crossref
Crossref
Yu-Ting Tseng, Yi-Hong Tsai, Ferenc Fülöp, Fang-Rong Chang & Yi-Ching Lo. (2019) 2-Iodo-4′-Methoxychalcone Attenuates Methylglyoxal-Induced Neurotoxicity by Activation of GLP-1 Receptor and Enhancement of Neurotrophic Signal, Antioxidant Defense and Glyoxalase Pathway. Molecules 24:12, pages 2249.
Crossref
Crossref
Agnete Kirkeby & Roger A. Barker. (2019) Parkinson disease and growth factors — is GDNF good enough?. Nature Reviews Neurology 15:6, pages 312-314.
Crossref
Crossref
Asya Ozkizilcik, Aruna Sharma, José Vicente Lafuente, Dafin F. Muresanu, Ala Nozari, Z. Ryan Tian, Herbert Mössler & Hari Shanker Sharma. 2019. Nanoneuroprotection and Nanoneurotoxicology. Nanoneuroprotection and Nanoneurotoxicology
201
246
.
Ibon GaritaonandiaRodolfo GonzalezGlenn ShermanAndrey SemechkinAndrew EvansRussell Kern. (2018) Novel Approach to Stem Cell Therapy in Parkinson's Disease. Stem Cells and Development 27:14, pages 951-957.
Crossref
Crossref
Daniel Mendes Filho, Patrícia d.C. Ribeiro, Lucas F. Oliveira, Diógenes R.M. de Paula, Vanessa Capuano, Thaís S.F. de Assunção & Valdo J.D. da Silva. (2018) Therapy With Mesenchymal Stem Cells in Parkinson Disease. The Neurologist 23:4, pages 141-147.
Crossref
Crossref
Mariateresa Allocca, Sheri Zola & Paola Bellosta. 2018. Drosophila melanogaster - Model for Recent Advances in Genetics and Therapeutics. Drosophila melanogaster - Model for Recent Advances in Genetics and Therapeutics.
C. Requejo, J. A. Ruiz-Ortega, H. Bengoetxea, A. García-Blanco, E. Herrán, A. Aristieta, M. Igartua, J. L. Pedraz, L. Ugedo, R. M. Hernández & J. V. Lafuente. (2016) Morphological Changes in a Severe Model of Parkinson’s Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors. Molecular Neurobiology 54:10, pages 7722-7735.
Crossref
Crossref
Fang Fang, Wanlin Yang, Jazmin B. Florio, Edward Rockenstein, Brian Spencer, Xavier M. Orain, Stephanie X. Dong, Huayan Li, Xuqiao Chen, Kijung Sung, Robert A. Rissman, Eliezer Masliah, Jianqing Ding & Chengbiao Wu. (2017) Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson’s disease. Scientific Reports 7:1.
Crossref
Crossref
TuaneBazanella Sampaio, AnneSuely Savall, MariaEduarda Ziani Gutierrez & Simone Pinton. (2017) Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy. Neural Regeneration Research 12:4, pages 549.
Crossref
Crossref
Sophia M. Raefsky & Mark P. Mattson. (2017) Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance. Free Radical Biology and Medicine 102, pages 203-216.
Crossref
Crossref
Jose V. Lafuente, Catalina Requejo, Alejandro Carrasco & Harkaitz Bengoetxea. 2017. Nanomedicine in Central Nervous System Injury and Repair. Nanomedicine in Central Nervous System Injury and Repair
99
122
.
John C. Ashton, Megan J. Dowie & Michelle Glass. 2017. The Endocannabinoid System. The Endocannabinoid System
115
186
.
Ian P. Johnson. (2015) Age-related neurodegenerative disease research needs aging models. Frontiers in Aging Neuroscience 7.
Crossref
Crossref
Óscar Cordero-Llana, Benjamin C Houghton, Federica Rinaldi, Hannah Taylor, Rafael J Yáñez-Muñoz, James B Uney, Liang-Fong Wong & Maeve A Caldwell. (2015) Enhanced Efficacy of the CDNF/MANF Family by Combined Intranigral Overexpression in the 6-OHDA Rat Model of Parkinson's Disease. Molecular Therapy 23:2, pages 244-254.
Crossref
Crossref
Tiago Martins Rodrigues, André Jerónimo-Santos, Tiago Fleming Outeiro, Ana Maria Sebastião & Maria José Diógenes. (2014) Challenges and Promises in the Development of Neurotrophic Factor-Based Therapies for Parkinson’s Disease. Drugs & Aging 31:4, pages 239-261.
Crossref
Crossref
Anna Effenberg, Alexander Klein, Robbin Gibb, Cathy Carroll, Wolfgang Baumgärtner, Claudia Grothe & Andreas Ratzka. (2014) Adult hemiparkinsonian rats do not benefit from tactile stimulation. Behavioural Brain Research 261, pages 97-105.
Crossref
Crossref
Aisling M. Gavin, Sinéad Walsh, Sean Wyatt, Gerard W. O’Keeffe & Aideen M. Sullivan. (2014) 6-Hydroxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivo. Neuroscience Letters 561, pages 176-181.
Crossref
Crossref
Minhua Zhang, Guangrui Luo, Yanjiao Zhou, Shaohui Wang & Zhong Zhong. (2014) Phenotypic Screens Targeting Neurodegenerative Diseases. SLAS Discovery 19:1, pages 1-16.
Crossref
Crossref
Boris Kantor, Thomas McCown, Paola Leone & Steven J. Gray. 2014.
71
124
.
Cai Song, Ye Zhang & Yilong Dong. (2013) Acute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration. Journal of Neuroinflammation 10:1.
Crossref
Crossref
Gaynor A. Smith & Evan Y. Snyder. (2013) Two cells are better than one: Optimizing stem cell survival by co-grafting “helper” cells that offer regulated trophic support. Experimental Neurology 247, pages 751-754.
Crossref
Crossref
Xiao-Yang Liao, Wei-Wen Wang, Zheng-Hui Yang, Jun Wang, Hang Lin, Qing-Song Wang, Yu-Xian Wu & Yu Liu. (2013) Microarray Analysis of Transcriptome of Medulla Identifies Potential Biomarkers for Parkinson’s Disease. International Journal of Genomics 2013, pages 1-7.
Crossref
Crossref
Marco Timmer & Guido Nikkhah. (2012) A novel strategy for intrastriatal dopaminergic cell transplantation: Sequential “nest” grafting influences survival and behavioral recovery in a rat model of Parkinson's disease. Experimental Cell Research 318:20, pages 2531-2542.
Crossref
Crossref
Takeshi Takarada, Noritaka Nakamichi, Hirofumi Kawagoe, Masato Ogura, Ryo Fukumori, Ryota Nakazato, Koichi Fujikawa, Miki Kou & Yukio Yoneda. (2012) Possible neuroprotective property of nicotinic acetylcholine receptors in association with predominant upregulation of glial cell line-derived neurotrophic factor in astrocytes. Journal of Neuroscience Research 90:11, pages 2074-2085.
Crossref
Crossref
Massimo S. Fiandaca, Krystof S. Bankiewicz & Howard J. Federoff. (2012) Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications. Pharmaceuticals 5:6, pages 553-590.
Crossref
Crossref
Xiaoyu Sun, Zhongkui Xiong, Yongfang Zhang, Ya Meng, Gang Xu, Zhiming Xia, Jiamei Li, Rui Zhang, Zunji Ke, Zongqin Xia & Yaer Hu. (2012) Harpagoside attenuates MPTP/MPP+ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor. Journal of Neurochemistry, pages no-no.
Crossref
Crossref
Jonathan R. Evans, Sarah L. Mason & Roger A. Barker. 2012. Functional Neural Transplantation III - Primary and Stem Cell Therapies for Brain Repair, Part I. Functional Neural Transplantation III - Primary and Stem Cell Therapies for Brain Repair, Part I
169
198
.
Aideen M. Sullivan & André Toulouse. (2011) Neurotrophic factors for the treatment of Parkinson's disease. Cytokine & Growth Factor Reviews 22:3, pages 157-165.
Crossref
Crossref
Kumar Sapkota, Seung Kim, Se-Eun Park & Sung-Jun Kim. (2010) Detoxified Extract of Rhus verniciflua Stokes Inhibits Rotenone-Induced Apoptosis in Human Dopaminergic Cells, SH-SY5Y. Cellular and Molecular Neurobiology 31:2, pages 213-223.
Crossref
Crossref
T. Kaplinovsky & A.M. Cunningham. (2011) Differential expression of RET receptor isoforms in the olfactory system. Neuroscience 175, pages 49-65.
Crossref
Crossref
Patrice P. Denèfle. 2011. Viral Vectors for Gene Therapy. Viral Vectors for Gene Therapy
27
44
.
Dustin R. Wakeman, Hemraj B. Dodiya & Jeffrey H. Kordower. (2011) Cell Transplantation and Gene Therapy in Parkinson's Disease. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 78:1, pages 126-158.
Crossref
Crossref
Tatsuya Ohnuki, Atsushi Nakamura, Shigeru Okuyama & Shoji Nakamura. (2010) Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease. Brain Research 1346, pages 26-42.
Crossref
Crossref
Teri R. Thomsen & Robert L. Rodnitzky. (2010) Juvenile Parkinsonism. CNS Drugs 24:6, pages 467-477.
Crossref
Crossref
G. Xu, Z. Xiong, Y. Yong, Z. Wang, Z. Ke, Z. Xia & Y. Hu. (2010) Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum. Neuroscience 167:1, pages 174-184.
Crossref
Crossref
Li Rebekah Feng & Kathleen A. Maguire-Zeiss. (2010) Gene Therapy in Parkinsonʼs Disease. CNS Drugs 24:3, pages 177-192.
Crossref
Crossref
Naoki Ishimaru, Mamoru Fukuchi, Akina Hirai, Yusuke Chiba, Tomonari Tamura, Nami Takahashi, Akiko Tabuchi, Masaaki Tsuda & Masahiko Shiraishi. (2010) Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2′-deoxycytidine in Neuro-2a cells. Biochemical and Biophysical Research Communications 394:1, pages 173-177.
Crossref
Crossref
Fabio Blandini, Lidia Cova, Marie-Therese Armentero, Eleonora Zennaro, Giovanna Levandis, Patrizia Bossolasco, Cinzia Calzarossa, Manuela Mellone, Busca Giuseppe, Giorgio Lambertenghi Deliliers, Elio Polli, Giuseppe Nappi & Vincenzo Silani. (2010) Transplantation of Undifferentiated Human Mesenchymal Stem Cells Protects against 6-Hydroxydopamine Neurotoxicity in the Rat. Cell Transplantation 19:2, pages 203-218.
Crossref
Crossref
M.G. Calavia, J. Feito, L. López-Iglesias, F. de Carlos, O. García-Suarez, P. Pérez-Piñera, J. Cobo & J.A. Vega. (2010) The lamellar cells in human Meissner corpuscles express TrkB. Neuroscience Letters 468:2, pages 106-109.
Crossref
Crossref
J. Fernando Bazan & Christian Wiesmann. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling
277
285
.
Roger A. Barker. (2009) Parkinson's disease and growth factors – are they the answer?. Parkinsonism & Related Disorders 15, pages S181-S184.
Crossref
Crossref
Ofer SadanMerav Bahat-StromzaYael BarhumYossef S. LevyAnat PisnevskyHagit PeretzAvihay Bar IlanShlomo BulvikNoam ShemeshDana KrepelYoram CohenEldad MelamedDaniel Offen. (2009) Protective Effects of Neurotrophic Factor–Secreting Cells in a 6-OHDA Rat Model of Parkinson Disease. Stem Cells and Development 18:8, pages 1179-1190.
Crossref
Crossref
Jesper Roland Jørgensen, Lachlan Thompson, Lone Fjord-Larsen, Christina Krabbe, Malene Torp, Nisse Kalkkinen, Claus Hansen & Lars Wahlberg. (2009) Characterization of Meteorin—An Evolutionary Conserved Neurotrophic Factor. Journal of Molecular Neuroscience 39:1-2, pages 104-116.
Crossref
Crossref
Andreas Androutsellis-TheotokisMaria A. RuegerDeric M. ParkHaik MkhikianErica KorbSteve W. PoserStuart Walbridge, Jeeva Munasinghe, Alan P. Koretsky, Russel R. Lonser & Ronald D. McKay. (2009) Targeting neural precursors in the adult brain rescues injured dopamine neurons. Proceedings of the National Academy of Sciences 106:32, pages 13570-13575.
Crossref
Crossref
Francesca Boscia, Carla Lucia Esposito, Antonella Di Crisci, Vittorio de Franciscis, Lucio Annunziato & Laura Cerchia. (2009) GDNF Selectively Induces Microglial Activation and Neuronal Survival in CA1/CA3 Hippocampal Regions Exposed to NMDA Insult through Ret/ERK Signalling. PLoS ONE 4:8, pages e6486.
Crossref
Crossref
Anette Fransson, Leif E. Järlebark & Mats Ulfendahl. (2009) In vivo infusion of UTP and uridine to the deafened guinea pig inner ear: Effects on response thresholds and neural survival. Journal of Neuroscience Research 87:7, pages 1712-1717.
Crossref
Crossref
Mari PalgiRiitta LindströmJohan PeränenT. Petteri Piepponen, Mart SaarmaTapio I. Heino. (2009) Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic neurons. Proceedings of the National Academy of Sciences 106:7, pages 2429-2434.
Crossref
Crossref
Zhi Dong Zhou, Sze Yen Kerk, Gao Gao Xiong & Tit Meng Lim. (2009) Dopamine auto-oxidation aggravates non-apoptotic cell death induced by over-expression of human A53T mutant alpha-synuclein in dopaminergic PC12 cells. Journal of Neurochemistry 108:3, pages 601-610.
Crossref
Crossref
Belal Rahhal, Stephan Heermann, Anika Ferdinand, Joachim Rosenbusch, Michael Rickmann & Kerstin Krieglstein. (2008) In vivo requirement of TGF‐β/GDNF cooperativity in mouse development: focus on the neurotrophic hypothesis. International Journal of Developmental Neuroscience 27:1, pages 97-102.
Crossref
Crossref
Daniel J. Abrams. 2009. Neuromodulation. Neuromodulation
977
983
.
Maria A. Mena & Justo García de Yébenes. (2008) Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia. The Neuroscientist 14:6, pages 544-560.
Crossref
Crossref